A team of University of California, Irvine researchers has discovered a possible reason why L-dopa, the front-line drug for treating Parkinson's disease, loses efficacy and causes dyskinesia—involuntary, erratic muscle ...
Jan 20, 2022
0
254
Deep Brain Stimulation (DBS) implanted in early stage Parkinson's disease decreases the risk of disease progression and the need to prescribe multiple drugs to patients simultaneously, according to a five-year outcomes study ...
Jun 29, 2020
0
107
Oxidative stress plays a big role in the brain cell loss that occurs in Parkinson's disease. Now scientists have their sights on a protein that inhibits one of the body's natural protections against it.
Nov 6, 2017
0
106
Researchers have solved a decade-long mystery about a critical protein linked to Parkinson's disease that could help to fast-track treatments for the incurable disease.
Dec 23, 2021
0
110
(HealthDay)—Almost any exercise is good medicine for someone with Parkinson's disease, a new study confirms.
Dec 22, 2016
0
723
Systemic treatment of animal models with israpidine, a calcium channel inhibitor, reduced mitochondrial stress that might cause Parkinson's disease, according to a Northwestern Medicine study published in the Journal of Clinical ...
Jun 27, 2018
0
233
A team of engineers from Apple Inc. working with researchers from several institutions in the U.S. has found that smartwatches could provide a valuable resource in helping to track the progression of Parkinson's disease in ...
While movement problems are the main symptoms of Parkinson's disease, people with the disease often have non-motor symptoms such as constipation, daytime sleepiness and depression 10 or more years before the movement problems ...
Aug 19, 2020
0
149
Research from The University of Queensland could lead to a new treatment for Parkinson's disease, with future potential applications to nearly 50 other disorders.
Aug 29, 2016
0
442
For patients with Parkinson disease on levodopa therapy, patient-rated quality of life is similar for those receiving adjuvant therapy with dopamine agonists compared with dopamine reuptake inhibitors (DRIs); and among DRIs, ...
Dec 29, 2021
0
18
